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Background and purpose: Currently, the inhomogeneity of the pulmonary function is not considered when
treatment plans are generated in thoracic cancer radiotherapy. This study evaluates the dose of treatment plans on
highly-functional volumes and performs functional treatment planning by incorporation of ventilation data from 4D-CT.
Materials and methods: Eleven patients were included in this retrospective study. Ventilation was calculated using
4D-CT. Two treatment plans were generated for each case, the first one without the incorporation of the ventilation
and the second with it. The dose of the first plans was overlapped with the ventilation and analyzed. Highly-functional
regions were avoided in the second treatment plans.
Results: For small targets in the first plans (PTV < 400 cc, 6 cases), all V5, V20 and the mean lung dose values for the
highly-functional regions were lower than that of the total lung. For large targets, two out of five cases had higher V5
and V20 values for the highly-functional regions. All the second plans were within constraints.
Conclusion: Radiation treatments affect functional lung more seriously in large tumor cases. With compromise of dose
to other critical organs, functional treatment planning to reduce dose in highly-functional lung volumes can be
achieved
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Radiotherapy that avoids or reduces radiation dose in
highly-functional lung regions might allow pulmonary
toxicity reduction to improve survival of lung cancer
patients [1]. Preservation of functional lung is becoming a
focus in radiation oncology now. Radiation treatment
planning with the incorporation of functional lung images
to decrease radiation dose in highly-functional lung re-
gions was reported in previous studies [2-8]. The feasibi-
lity of using lung perfusion information obtained from
single photon emission computed tomography (SPECT)
has been investigated previously [4,5]. The identification
of good functional lung ventilation using SPECT coupled
with intensity modulated radiation therapy (IMRT) is
an attractive strategy [6]. The incorporation of simulation* Correspondence: tzungchi.huang@mail.cmu.edu.tw
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reproduction in any medium, provided the orfrom SPECT or 3He-MRI into IMRT planning for non-
small cell lung cancer (NSCLC) was studied [2]. The in-
corporation of four-dimensional computed tomography
(4D-CT) ventilation information is the latest technology
reported in several studies for radiotherapy planning pur-
poses [3,7,8]. These studies focused on NSCLC of small
targets in which a flexible beam arrangement can be easily
made in functional treatment planning. The functional
planning with IMRT for large thoracic tumors, including
lung and esophagus cancers, are absent in studies so far.
The retrospective research on dose distribution in the
highly-functional lung regions was not performed.
Different imaging modalities are currently used clinica
lly for pulmonary ventilation evaluation. Nuclear medi-
cine, including nuclear scintigraphy [9], SPECT [10],
positron emission tomography (PET) [11], is the most
commonly used modality. Magnetic resonance imaging
(MRI) [12] and CT [13] are also capable of pulmonary
functional imaging. However, these approaches are notLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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imaging settings would increase treatment cost and
patient waiting time. Lately, ventilation imaging calcu-
lated using deformable image registration (DIR) with
4D-CT becomes a hot topic [14-16]. Lung scans of the
whole respiration cycle are available by 4D-CT which
provides the structural tissue locations in different time-
phases. With the aids of DIR, linking phase to phase of
CT sets for motion estimation of lung tissues in the res-
piration cycle, ventilation information can be acquired.
Castillo et al. generated ventilation image using the
Hounsfield unit change or Jacobian determinant of the
deformation field to estimate the local volume changes.
The measurement of regional ventilation change in lung
due to radiotherapy using 4D-CT and DIR techniques was
reported by Ding et al. [17]. The 4D-CT ventilation image
provides 3D high resolution ventilation information which
can by incorporated in treatment planning to maximize
the preservation of functional lung and improve the radia-
tion treatment for thoracic cancer patients.
The primary purpose of this study was to evaluate the
radiation dose of IMRT treatment plans on functional
lung volumes and to generate IMRT plans by the in-
corporation of functional lung imaging from 4D-CT for
thoracic cancer patients. With functional lung regions
avoided by beam angle optimization and IMRT inverse-
planning, thereby presumably minimizing the risk of
both acute and late complications is achieved. Various
tumor sizes were included in this study. The dosimetric




Eleven patients who had non-trivial but stable respiration
motion and received 4D-CT (PET/CT-16 slice, DiscoveryTable 1 Characteristics of study subjects and lesions
Patient Age(y) Histologic type
1 71 NSCLC,NOS #
2 64 NSCLC, Squamous Cell Cancer
3 49 Thymoma #
4 62 Small cell lung cancer
5 54 Thymoma #
6 52 Esophagus, Squamous Cell Cancer
7 41 NSCLC, Squamous Cell Cancer
8 56 Esophagus, Squamous Cell Cance
9 70 NSCLC, Squamous Cell Cancer
10 52 NSCLC, Esophagus, Squamous Cell Can
11 72 NSCLC, Squamous Cell Cancer
The location is labeled as RUL = right upper lobe, RLL = right lower lobe, LUL = le
NOS = not otherwise specified #: resection operation was performed before radiotSTE, GE Medical System, Milwaukee, Wisconsin USA)
imaging were included in this retrospective study. The
clinical characteristics of these eleven patients were pre-
sented in Table 1. Five NSCLS, one small cell lung cancer
(SCLC), three esophagus cancer and two thymoma cancer
patients of 8 males and 3 females made up the patient
study group. The mean age of the study group was 58
(range from 49 to 72). The range of planned target volume
(PTV) was from 62 to 805 cm3. The study group was
divided to two subgroups by PTV size. The subgroup with
the small PTV volume (≤400 cm3) consisted of 6 indivi-
duals. The mean volume was 217.6 cm3 ranging from 62.1
to 393.2 cm3. The subgroup with PTV volume exceeding
400 cm3 included 5 subjects with a mean volume of
710.9 cm3, ranging from 639.8 to 804.9 cm3.
The 4D-CT data were obtained using the Varian real-
time position management (RPM system, Varian Medical
Systems, Inc. Palo Alto, CA) with respiratory motion
tracked by an external marker. The collection and re-
view of the clinical data for this project was approved by
the ethical committee of the China Medical University
Hospital, Taiwan (DMR100-IRB-216).
IMRT planning
IMRT plans were generated on an Eclipse commercial
treatment-planning system, version 8.1 (Varian Medical
Systems) to deliver doses between 50–74 Gy to the PTV
depending on diagnosis. The maximum intensity projec-
tion tool was used with images of all respiration phases to
determine the internal gross target volume (IGTV). A
margin of 5 to 10 mm was added to the IGTV to form the
PTV. The time-averaged CT images [18] were used for
normal structure delineation and dose calculation in pla-
nning. Two treatment plans were generated for each case.
The first one, referred as anatomic plan, was generated
without the incorporation of ventilation information. TheStage Location PTV(cm3)
III RUL 62.1 cm3
III LUL 119.5 cm3
III 216.7 cm3
III RUL 253.5 cm3
III 260.7 cm3
# III 393.2 cm3
III RLL 639.8 cm3
r III 660.6 cm3
III Carina bronchial 716.6 cm3
cer # III LLL 732.8 cm3
III LLL 804.9 cm3
ft upper lobe and LLL = left lower lobe. NSCLC = non-small cell lung cancer;
herapy.
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95% of the PTV with maximal dose less than 110%
of the prescribed dose and to restrict the relative
volume of lung receiving a dose above 5 (V5), 10
(V10), and 20 Gy (V20) to be below 65%, 50%, and
35% respectively [19]. In the second plans, referred
as functional plans in which ventilation information
was incorporated, functional dose-volume constraints
that account for the inhomogeneous function of lung
were applied in IMRT planning. Regions of top 20%
ventilation in the 4D-CT based ventilation image
were set as avoid regions in the functional treatment
plans. In addition, gantry angles in the functional
plans were also changed from the anatomic plans to
avoid the highly functional regions. Dose volume
constraints for anatomic planning and functional
planning are listed in Table 2. All the final anatomic
and functional IMRT plans are clinically acceptable
in this study.Deformable image registration
DIR provides a voxel-to-voxel deformation matrix among
CT images from different phases of the respiratory
cycle. The deformation matrix is used to quantify the
density change within a particular voxel over the
time course of the respiratory cycle. We previously
developed the DIR method based on optical flow
method [20] for tumor motion estimation across 4D-
CT [21,22]. The validation was reported with 1 mm
accuracy [22].Table 2 Dose volume constraints for anatomic planning and f
radiotherapy (IMRT)
Anatomic
Structure Constraint type Dose Volume
GTV Maximum dose 105% 0%
Minimum dose 103% 100%
CTV Maximum dose 105% 0%
Minimum dose 102% 100%
PTV Maximum dose 105% 0%
Minimum dose 101% 100%
Total lung Maximum dose 5 Gy 30%
Maximum dose 10 Gy 25%
Maximum dose 20 Gy 20%
Functional lung Maximum dose
Maximum dose
Maximum dose
Spinal cord Maximum dose 40 Gy 0%
Spinal cord + 5 mm Maximum dose 45 Gy 0%Ventilation image
Pulmonary ventilation P can be defined as the fractional





where V is the local volume at expiration and ΔV is the
volume change from expiration to inspiration.
Considering two extreme phases of CT image sets
among 4D-CT data, one taken at normal end expiration
and the other at normal end inspiration, the volume of
each voxel in expiration is a constant, determined by the
CT voxel size. The voxel volume in expiration is expanded
in inspiration. The boundary of a cube defined by 8 voxels
in the expiration image set is deformed and no longer the
same in the inspiration image set. DIR determines the
new boundary location. The volume calculation program
calculates the volume of the polyhedron deformed from
the cube. The volume change ΔV is the volume difference
between expiration and inspiration.
Paired CT images from 4D-CT at the normal end expi-
ration and normal end inspiration phases were used for
ventilation computation. In the current study, the defini-
tions of highly-functional lung volumes were divided into
top 20%, 30% and 40% in a ventilation image, respectively.
Treatment plan analysis
The concepts of mean lung dose (MLD), V5 and V20 are
no longer just applied to the total lung, but also applied tounctional planning used for intensity-modulated
planning Functional planning
(%) Priority Dose Volume (%) Priority
50 105% 0% 50
450 103% 100% 450
400 105% 0% 400
400 102% 100% 400
650 105% 0% 650
350 101% 100% 350
200 5 Gy 30% 200
200 10 Gy 25% 200
200 20 Gy 20% 200
5 Gy 30% 250
10 Gy 25% 250
20 Gy 20% 250
300 40 Gy 0% 300
300 45 Gy 0% 300
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40% respectively. The 3D dose distributions from the ana-
tomic IMRT plans were overlapped with the 3D ventila-
tion distributions and analyzed. The analysis included the
comparison of the MLD, V5 and V20 of the high ventila-
tion volumes to that of the total lung. The differences bet-
ween anatomic planning and functional planning on the
dose and functional lung volume in small and large tumor
groups were tested for significance using the Student’s
t-test. Results were considered significant at p < 0.05.
Comparison of 90% conformity index (CI) and homo-
geneity index (HI) between anatomic and functional
plans were analyzed. The CI, a measure of dose con-




VPI  PTV ð2Þ
where PI means the prescription isodose which was 90%
of the prescription dose in this study, PTVPI is the vol-
ume in PTV that is covered by PI, VPI is the totalFigure 1 The transverse (a), coronal (b) and sagittal (c) views of a 4D-
views of 50%-0% (expiration-inspiration) ventilation of this example are sho
region (indicated by the arrow on the CT image) on the ventilation image.
motion range was large. This volume change difference can be observed o
black and 0.5 as white.volume, including PTV and normal tissue, that is cov-
ered by PI. The HI, a measure of dose homogeneity, is
defined as
HI ¼ D2%  D98%
DP
ð3Þ
where D2% is the high dose that covers 2% of PTV vol-
ume, D98% is the dose that covers the rest 98% of PTV
and DP is the prescription dose.
Results
Figure 1 shows the difference between two extreme
phases, normal end inspiration phase and the normal
end expiration phase for a 4D-CT image set of a lung
cancer patient in transverse (a) coronal (b) and sagittal
(c) views. The motion of the diaphragm can be observed
in Figure 1b and c (arrows) and the corresponding venti-
lation images are shown in Figure 1d ~ f. In this ex-
ample, different volume changes between left and right
lungs are indicated by the diaphragm motion range di-
fference in the overlapping CT images of the endCT. The arrow indicated the location of the tumor. Corresponding
wn as in (d), (e) and (f). Low ventilation is noticeable in the tumor
The arrows on the CT image set indicate that the right diaphragm
n the ventilation image. The ventilation image is scaled as ΔV/V = 0 as
Huang et al. Radiation Oncology 2013, 8:3 Page 5 of 10
http://www.ro-journal.com/content/8/1/3expiration and inspiration phases. The 3 cm motion of
the right diaphragm and 0.5 cm motion of the left dia-
phragm were observed. The ventilation difference of the
left and right lungs can be seen on the corresponding
ventilation image. Lower ventilation around lung tumor
region was also observed in this example (Figure 1d).
Figure 2a shows the overlap of highly-functional lung
volumes (ventilation of top 20%, 30% and 40%) on an ana-
tomic IMRT plan as an example. The corresponding
dose-volume histogram (DVH) was shown on Figure 2b.
All anatomic IMRT plans show that a relatively homoge-
neous dose in the target volume wasachieved with theFigure 2 (a) Dose distribution of an anatomic IMRT treatment plan w
(functional) volume histogram (DVH or DFVH) of the highly-functiona
cancer patient.high dose regions conform to the target. The comparison
between the large tumor and the small tumor subgroups
shows that more critical structure sparing was achieved in
the small tumor plans than in the large tumor plans.
Table 3 lists the values of V5, V20 and MLD in total
lung and top 20%, 30% and 40% functional lung regions
for all the investigated anatomic treatment plans. The
IMRT plan constraints, which included the radiation
dose for lung V20≦30-35% and V5≦70% (NCCN
Clinical Practice Guidelines in Oncology Non-Small Cell
Lung Cancer version 2.2012), were all reached. For the
cases of small target volumes (6 cases in total), all V5,ith high ventilation regions, as an example (b) The dose–
l lung region, at 20%, 30% and 40% for a large volume of NSCLS
Table 3 Values of V5, V20 and mean lung dose (MLD) in total lung and top 20%, 30% and 40% functional lung regions
for all the investigated anatomic treatment plans
Patient Anatomic Functional lung region
Total lung 20% 30% 40%
V5 (%) V20 (%) MLD
(Gy)
V5 (%) V20 (%) MLD
(Gy)
V5 (%) V20 (%) MLD
(Gy)
V5 (%) V20 (%) MLD
(Gy)
1 11.6 7.1 3.8 5.1 2.6 1.6 7.9 4.4 2.6 9.4 5.6 3.2
2 26.74 16.9 9.3 17.9 9.7 5.5 21 11.8 6.7 22.9 13.4 7.6
3 50.6 18.6 11.07 40.6 15.8 9.4 42.6 17 9.9 42.6 17.4 10
4 25.2 17.8 9.4 16.1 10.6 5.8 19.6 13.3 7.2 22.3 15.5 8.3
5 47.3 16.8 10.3 29.2 8.3 6 36.2 12 7.9 40.1 13.9 8.8







8.7 ± 2.6 22.7 ±
12.3









7 66.4 30.3 16.7 67.4 31.2 17.1 67.1 30 16.8 67.1 30 16.7
8 34.4 18.3 8.7 38.3 21.8 9.9 36.7 20.4 9.3 36.4 20.2 9.3
9 57.7 25.7 13.2 45 19.3 10.2 51.5 23 11.9 55.5 25.1 12.9
10 62.1 27.2 14.4 64.1 26 14.1 62.3 25.3 13.7 61.1 25 13.6
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top 20%, 30% and 40% ventilation, were lower than the
values for the total lung. For the cases of large target
volumes, two out of five cases had lower V5 and V20
values (Case 9, 11) in the highly-functional regions (top
20%) compared with the total lung. For the small tumor
volume subgroup, when compared to the anatomic
plans, the decrease in percentage of volume and dose for
V5, V20 and MLD in total lung and the top 20% func-
tional lung regions in the functional plans was statisti-
cally significant as demonstrated in Figure 3a. For the
large tumor subgroup, the significant difference only
appears on the percentage of volume for V5 in the top
20% functional lung regions (Figure 3b).
The 90% CI and HI for each plan of all 11 cases are
listed in Table 4. Table 5 presents the summary in com-
parisons of the doses of total lung, functional lung,
heart, spinal cord and esophagus between the anatomic
and functional plans from all cases. In terms of lung
doses, functional plans had lower doses in average com-
pared with those in anatomic plans. For other organs at
risk (OAR), functional planning led to greater doses than
anatomic planning. The low dose region in lungs (about
12 Gy) was clearly improved in the functional plans.
Discussion
In this retrospective study, the ventilation image derived
from 4D-CT was applied for evaluation of radiotherapy
treatment plans in functional lung sparing. One way to
compare functional lung sparing is to compare the MLDfor total lung and highly-functional lung. Based on the
cases studied, for small target volume cases, the MLD of
total lung was always higher than that of highly-
functional lung volumes (20% ~ 40%). The reason for
this is that the volume around tumor is usually of low
ventilation, and for small targets, radiation beams cover
smaller normal lung volume, thus affect less highly-
functional lung volume. However, the consistent results
were not found in this study for large target volume
cases. The number of cases that the MLD in highly-
functional lung volumes was higher than that of the total
lung was about the same as the number of cases that the
MLD in highly-functional lung volumes was lower, since
the beams to cover large target volumes would go
through large normal lung volume, which inevitably
include highly-functional lung volume. The difference
between the MLD values in highly-functional lung
volumes and in the total lung was not great. While Case
7 to 10 are typical examples, Case 11 is an exception.
The big tumor in Case 11 was in the left lung. The radi-
ation beams were arranged to avoid the right lung com-
pletely where most the high ventilation lung volume was
in. Thus in this case, the MLD of total lung was ob-
viously higher than that of the highly-functional lung
volumes.
In treatment planning, clinicians always try to
minimize the radiation dose to normal lungs to reduce
toxicity, usually without functional lung information
[25]. The dose in highly-functional lung regions deter-
mines the risk of complication and thus should be an
Figure 3 (a) Comparison of dosimetric parameters between anatomic and functional plans for small tumor cases and (b) for large
tumor cases.
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retrospective study investigates the dose in highly-
functional lung volumes in the treatment plans developed
without incorporation of the functional lung information.
For small tumors, V5, V20 and MLD of highly-functional
lung regions were mostly lower than the values of total
lung. This implies that even without incorporation of
functional lung information in IMRT treatment planning,the dose in highly-functional lung regions is usually low.
For large tumors, it varies case by case. But in general,
radiation treatment affects functional lung more when the
target volume is large. From this point of view, it is more
critical to incorporate functional lung information in
treatment planning for patients with large tumors. It may
be more difficult to achieve certain goals in functional
lung sparing for large target volumes due to anatomical
Table 4 The prescription dose, conformity index (CI), heterogeneity index (HI) and the number of monitor units (MU)





Anatomic planning Functional planning
PTV PTV
90%CI HI MU Mean (%) 90%CI HI MU Mean (%)
1 NSCLC 6000 62.1 0.34 0.08 741 102.6 0.31 0.11 999 102.6
2 NSCLC 7400 119.5 0.68 0.07 387 101.9 0.62 0.10 724 101.9
3 Thymoma 5400 216.7 0.56 0.10 513 102.3 0.53 0.15 605 102.3
4 SCLC 5400 253.5 0.56 0.14 551 102.2 0.47 0.13 1182 102.2
5 Thymoma 5040 260.7 0.57 0.12 517 102.4 0.52 0.15 705 102.4
6 Esophagus 5040 393.2 0.64 0.11 734 102.4 0.75 0.13 790 102.4
7 NSCLC 5000 639.8 0.66 0.14 1060 100.9 0.64 0.11 1163 100.9
8 Esophagus 5040 660.6 0.61 0.12 960 102.5 0.40 0.12 973 102.5
9 NSCLC 5000 716.6 0.67 0.09 867 101.9 0.60 0.13 1291 101.9
10 Esophagus + NSCLC 5040 732.8 0.67 0.09 962 102.0 0.66 0.12 1074 102.0
11 NSCLC 6000 804.9 0.61 0.10 1367 101.1 0.47 0.12 1302 101.1
CI ¼ PTVPIPTVPIVPIPTV
CI : Conformity index.
PI : prescription isodose line.
PTVPI : planning target volume within the prescribed isodose volume PI;
VPI : volume of the prescription isodose line;
PTV : planning targe volume.
HI ¼ D2%  D98%DP
HI: Homogenity index.
D2%: represent the doses to 2% of the PTV.
D98%: represent the doses to 98% of the PTV.
DP: Prescription Dose.
Table 5 Summary of lung dose and critical organs for
anatomic and functional treatment plans among 11
thoracic cancer patients
Metric Anatomic planning Functional planning
Total lung
V5 (%) 42.77 ± 16.97 36.97 ± 17.05
V20(%) 20.44 ± 6.99 18.12 ± 8.11
MLD (Gy) 11.24 ± 4.03 10.19 ± 4.36
20% Functional lung
V5 (%) 34.76 ± 19.21 28.61 ± 19.45
V20(%) 15.22 ± 8.59 12.57 ± 8.85
MLD (Gy) 8.61 ± 4.35 7.38 ± 4.59
Heart
V40 (%) 16.75 ± 15.05 21.87 ± 23.12
Mean dose (Gy) 16.7 ± 12.78 17.31 ± 13.95
Spinal cord
Maximun (Gy) 41.58 ± 5.73 43.31 ± 4.5
Esophagus
V35 (%) 20.36 ± 16.14 24.15 ± 17.36
V50 (%) 11.57 ± 16.95 11.57 ± 16.96
Mean dose (Gy) 15.34 ± 9.23 16.22 ± 9.31
Abbreviations:
VX(%): volume of an OAR receiving ≧ X Gy; MLD: Mean lung dose; Data
presented as mean ± standard deviation.
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ing should be easier to accomplish because a more flexible
beam arrangement is possible. This study has demon-
strated this trend (Figure 3).
With the highly-functional lung sparing constraints, all
cases showed better V5 in the functional plans (Figure 3).
Most functional plans demonstrated significant improve-
ment in V5, V20 and MLD in the top 20% high ventila-
tion volumes. Based on the MLD to total lung, there is
only one functional plan in which the MLD to total lung
was higher in the functional plans by 0.05 Gy. The rea-
son for this was that the tumor was oblong in shape and
close to the esophagus. When the objectives of proper
PTV coverage and highly-functional lung sparing in the
functional plans were satisfied, the MLD to the total
lung got slightly worse.
In general, all functional plans generated with incor-
poration of 4D-CT based ventilation image for all tho-
racic cancer patients were successfully within constraints
(Table 2) and acceptable for clinical use. Among the 11
cases studied, when compared with the anatomic plans,
both better CI and HI in the functional plan were found
in one case, better CI and superior HI in the functional
plan were found in 1 and 9 cases respectively. More
cases in the anatomic plans had better CI (10 out of 11)
while more in the functional plans had better HI (9 out
of 11). However, the differences are within a small
Huang et al. Radiation Oncology 2013, 8:3 Page 9 of 10
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differences showed no strong relationship with the
tumor size but more related to the shape and location
relative to critical organs. Since there are more con-
straints in the functional planning, one would expect
worse CI and HI in functional plans when compared
with the anatomic plans. This trend is not clear for HI
in this study.
The dose to the other OARs, such as heart, spinal cord
and esophagus, were relatively higher in the functional
plans than that in the anatomic plans. Since the doses to
the other OARs in the functional plans were within the
planning constraints, they were not forced to be better
than the anatomic plans. Tighter doses to the other
OARs could be achieved if tighter dose constraints to
other OARs were made. However, since there are more
planning constraints in the functional planning, some
compromise has to be made, which could be the doses
to the other OARs. If tighter doses to the other OARs
are not achievable, one needs to evaluate the risks of
complications to the lung and other OARs and make de-
cision which plan to use, the anatomic or functional
plan.
A recent study showed that the poor initial ventilation
close to the tumor may improve with treatment induced
tumor shrinkage [26]. Although lower V20 and MLD are
recommended to limit the risk of radiation pneumonitis
in general [1], many other studies showed that the pul-
monary injury and radiation dose had a weak correlation
[17,27,28]. Hence, the hypothesis that sparing of the best
functioning lung volumes is beneficial for the patients
still needs to be verified by clinical data.
Conclusion
This study has demonstrated the evaluation of radiation
dose of IMRT treatment plans on functional lung volumes
by incorporation of functional lung imaging from 4D-CT
for thoracic cancer patients. Radiation treatments affect
functional lung volumes more seriously on larger tumor
cases than that of smaller ones. Thus it is more critical to
arrange radiation beams for functional lung sparing for
patients with large tumors. Anatomic and functional treat-
ment plans with 4D-CT-based ventilation imaging for
thoracic cancer patients including NSCLC, thymoma and
esophaguys tumors are presented and were all clinical
acceptable. With some compromise of dose to other crit-
ical organs, the dose reduction in highly-functional lung
regions to reduce lung toxicity can be achieved.
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